vatalanib has been researched along with acrolein in 1 studies
Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (acrolein) | Trials (acrolein) | Recent Studies (post-2010) (acrolein) |
---|---|---|---|---|---|
276 | 42 | 98 | 3,386 | 48 | 1,636 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, W; Fan, T; Fu, P; Han, L; Ishii, M; Liu, K; Liu, R; Lv, C; Runyon, RS; Yuan, X; Zeng, H; Zhang, W | 1 |
1 other study(ies) available for vatalanib and acrolein
Article | Year |
---|---|
Cinnamaldehyde accelerates wound healing by promoting angiogenesis via up-regulation of PI3K and MAPK signaling pathways.
Topics: Acrolein; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phthalazines; Pyridines; Up-Regulation; Vascular Endothelial Growth Factor A; Wound Healing; Zebrafish | 2018 |